AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22545117 — intervention group
Group type: EXPERIMENTAL
Intervention: Training traditional birth attendants (TBAs)
Number of subjects: 0
Study 19364991 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-saturated-fat, low-cholesterol diet
Number of subjects: 1062
Study 19364991 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1062
Study 17516967 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolongation of pregnancy in early‐onset hypertensive disorders
Number of subjects: 216
Study 15382598 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music preoperatively and postoperatively
Number of subjects: 0
Study 11266263 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum concentrations of hepatocyte growth factor (HGF)
Number of subjects: 82
Study 11266263 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative nutritional state
Number of subjects: 82
Study 11266263 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative IL‐6 response
Number of subjects: 82
Study 11266263 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of infective complications
Number of subjects: 82
Study 10068082 — intervention group
Group type: EXPERIMENTAL
Intervention: S-phase fraction
Number of subjects: 4000
Study 10068082 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor size
Number of subjects: 4000
Study 10068082 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient age at surgery
Number of subjects: 4000
Study 10068082 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone receptor (PgR) status
Number of subjects: 4000
Study 7736480 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-adrenergic chronic therapy
Number of subjects: 0
Study 7736480 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring
Number of subjects: 0
Study 3437508 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapidil (400 mg daily on days 1 to 8, 200 mg on day 9)
Number of subjects: 10
Study 3437508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31014775 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)-epicatechin 1 mg/kg BW
Number of subjects: 20
Study 31014775 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)-epicatechin 0.5 mg/kg BW
Number of subjects: 20
Study 31014775 — intervention group
Group type: EXPERIMENTAL
Intervention: (−)-epicatechin 0.1 mg/kg BW
Number of subjects: 20
Study 31014775 — intervention group
Group type: COMPARATOR
Intervention: Water only (control)
Number of subjects: 20
Study 29679981 — intervention group
Group type: EXPERIMENTAL
Intervention: Red plates
Number of subjects: 54
Study 29679981 — intervention group
Group type: EXPERIMENTAL
Intervention: Black plates
Number of subjects: 54
Study 29679981 — intervention group
Group type: COMPARATOR
Intervention: White plates
Number of subjects: 54
Study 29679981 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between red and black plates
Number of subjects: 54
Study 26422126 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propranolol (0.15 mg/kg)
Number of subjects: 273
Study 23962422 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive software for weight self-monitoring (Intervention Group)
Number of subjects: 281
Study 23962422 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 281
Study 22649299 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic acupuncture
Number of subjects: 196
Study 22649299 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (control)
Number of subjects: 196
Study 21244805 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tendo-achilles lengthening (TAL)
Number of subjects: 18
Study 21244805 — intervention group
Group type: COMPARATOR
Intervention: Open tendo-achilles lengthening (TAL)
Number of subjects: 18
Study 19127002 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of electronic devices (PDAs and smartphones)
Number of subjects: 0
Study 19127002 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors influencing success
Number of subjects: 0
Study 19403495 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer leaflet without verbal explanation
Number of subjects: 41
Study 19403495 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter leaflet
Number of subjects: 41
Study 19403495 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal explanation (regardless of documentation style)
Number of subjects: 41
Study 19403495 — intervention group
Group type: COMPARATOR
Intervention: All groups (irrespective of documentation style)
Number of subjects: 41
Study 19403495 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation style (longer vs shorter)
Number of subjects: 41
Study 14967213 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual training associated with reading
Number of subjects: 0
Study 11318063 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial cues and attention in a Simon task
Number of subjects: 0
Study 9161744 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (0.05 mg.kg‐1)
Number of subjects: 80
Study 9161744 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg.kg‐1)
Number of subjects: 80
Study 9161744 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium and Lidocaine
Number of subjects: 80
Study 9161744 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 80
Study 9161744 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 80
Study 9161744 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 80
Study 8424378 — intervention group
Group type: EXPERIMENTAL
Intervention: PPA (75 mg osmotic release oral system (OROS)‐PPA/d)
Number of subjects: 24
Study 8424378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 8424378 — intervention group
Group type: EXPERIMENTAL
Intervention: PPA
Number of subjects: 24
Study 3122275 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (400 mcg)
Number of subjects: 20
Study 3122275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31741957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Dissection Technique (CDT)
Number of subjects: 534
Study 31741957 — intervention group
Group type: COMPARATOR
Intervention: Bipolar Electrocautery Technique (BET)
Number of subjects: 534
Study 27742998 — intervention group
Group type: EXPERIMENTAL
Intervention: EP217609 (4, 8, 12 mg)
Number of subjects: 36
Study 27742998 — intervention group
Group type: EXPERIMENTAL
Intervention: Avidin (30-min intravenous infusion)
Number of subjects: 36
Study 27742998 — intervention group
Group type: EXPERIMENTAL
Intervention: Avidin (2:1 and 3:1 molar ratios)
Number of subjects: 36
Study 27742998 — intervention group
Group type: EXPERIMENTAL
Intervention: EP217609 and Avidin
Number of subjects: 36
Study 26399451 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 16800 IU orally once a week for 1 year
Number of subjects: 240
Study 26399451 — intervention group
Group type: COMPARATOR
Intervention: Placebo orally once a week for 1 year
Number of subjects: 240
Study 25108749 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Massage (CM)
Number of subjects: 45
Study 25108749 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Massage (CTM)
Number of subjects: 45
Study 21969418 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 342
Study 21969418 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 342
Study 21969418 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 342
Study 21969418 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (Control)
Number of subjects: 342
Study 19687579 — intervention group
Group type: EXPERIMENTAL
Intervention: cilnidipine 5-10 mg/day
Number of subjects: 78
Study 19687579 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 5-7.5 mg/day
Number of subjects: 78
Study 17684620 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (7 grams per day for seven days)
Number of subjects: 17
Study 17684620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 15110198 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin (0.75 mg/kg bolus, 1.75 mg/kg/hour infusion during the procedure)
Number of subjects: 1056
Study 15110198 — intervention group
Group type: COMPARATOR
Intervention: Heparin (70 U/kg initial bolus)
Number of subjects: 1056
Study 15110198 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 1056
Study 15110198 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 1056
Study 11574500 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh spermatozoa (group A)
Number of subjects: 240
Study 11574500 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen-thawed spermatozoa (group B)
Number of subjects: 240
Study 9132880 — intervention group
Group type: EXPERIMENTAL
Intervention: Health related quality of life measurement
Number of subjects: 0
Study 9132880 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Surgery Reporting System registry
Number of subjects: 0
Study 9132880 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0
Study 9132880 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Outcome Research Teams (PORTs) projects
Number of subjects: 0
Study 7951291 — intervention group
Group type: COMPARATOR
Intervention: Static muscle stretch
Number of subjects: 0
Study 7951291 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic muscle stretch
Number of subjects: 0
Study 3608733 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbacet 25 micrograms four times daily
Number of subjects: 105
Study 3608733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 28779544 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D)
Number of subjects: 162
Study 28779544 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (A)
Number of subjects: 162
Study 28779544 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (C)
Number of subjects: 162
Study 27367766 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized rehabilitation therapy (SRT)
Number of subjects: 300
Study 27367766 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 25176376 — intervention group
Group type: EXPERIMENTAL
Intervention: 22.63 mg/kg emulsified isoflurane
Number of subjects: 3
Study 25176376 — intervention group
Group type: EXPERIMENTAL
Intervention: 38.26 mg/kg emulsified isoflurane
Number of subjects: 3
Study 25176376 — intervention group
Group type: EXPERIMENTAL
Intervention: 49.73 mg/kg emulsified isoflurane
Number of subjects: 3
Study 21636188 — intervention group
Group type: EXPERIMENTAL
Intervention: Active manuka honey 20 ml 4 times daily for 6 weeks
Number of subjects: 131
Study 21636188 — intervention group
Group type: COMPARATOR
Intervention: Placebo (golden syrup) 20 ml 4 times daily for 6 weeks
Number of subjects: 131
Study 21636188 — intervention group
Group type: EXPERIMENTAL
Intervention: Active manuka honey and Placebo (golden syrup)
Number of subjects: 131
Study 21029641 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu injection (SF injection) administered by peripheral intravenous infusion at initially 0.2 ml/kg and then 0.8 ml (kg/h) until the end of operations
Number of subjects: 24
Study 21029641 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group N) administered similarly
Number of subjects: 24
Study 21029641 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu injection (SF injection)
Number of subjects: 24
Study 21029641 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group N)
Number of subjects: 24
Study 18684185 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose lubiprostone (24 microg)
Number of subjects: 200
Study 18684185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 15516362 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants with RDS
Number of subjects: 52
Study 12322842 — intervention group
Group type: EXPERIMENTAL
Intervention: Songkla uterine manipulator (SUM)
Number of subjects: 40
Study 12322842 — intervention group
Group type: COMPARATOR
Intervention: Hulka controlling tenaculum
Number of subjects: 40
Study 10415055 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-TNF-alpha therapy
Number of subjects: 0
Study 7594063 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (n = 99)
Number of subjects: 245
Study 7594063 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 115)
Number of subjects: 245
Study 7594063 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine
Number of subjects: 245
Study 7594063 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (2 g/day)
Number of subjects: 245
Study 2255726 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g POT II in a high-protein soup vehicle (70 kcal)
Number of subjects: 11
Study 2255726 — intervention group
Group type: COMPARATOR
Intervention: soup vehicle alone
Number of subjects: 11
Study 2255726 — intervention group
Group type: COMPARATOR
Intervention: no-soup control
Number of subjects: 11
Study 6996625 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin combined with tobramycin
Number of subjects: 57
Study 6996625 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole combined with tobramycin
Number of subjects: 57
Study 31651314 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE Steps to Success programme (educational and development intervention)
Number of subjects: 3638
Study 31651314 — intervention group
Group type: EXPERIMENTAL
Intervention: Training provided to country trainers
Number of subjects: 3638
Study 31651314 — intervention group
Group type: EXPERIMENTAL
Intervention: Framework for cross-cultural adaptation
Number of subjects: 3638
Study 28107852 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical chamomile oil
Number of subjects: 86
Study 28107852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 25332071 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 197
Study 25332071 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CYC) followed by azathioprine (AZA)
Number of subjects: 197
Study 24167595 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-sweetened beverage
Number of subjects: 203
Study 24167595 — intervention group
Group type: COMPARATOR
Intervention: Sugar-free beverage
Number of subjects: 203
Study 21116816 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 650 mg every 6 hours for 3 days
Number of subjects: 793
Study 21116816 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin 80 mg single dose prior to ZOL infusion
Number of subjects: 793
Study 21116816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 793
Study 19508669 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelets stored for 1-5 days
Number of subjects: 60
Study 19508669 — intervention group
Group type: COMPARATOR
Intervention: Platelets stored for 6-7 days
Number of subjects: 60
Study 17786991 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resistance heat and moisture exchangers (HMEs)
Number of subjects: 20
Study 15291677 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 45
Study 15291677 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 45
Study 15291677 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine-Fluoxetine Combination (OFC)
Number of subjects: 45
Study 15291677 — intervention group
Group type: COMPARATOR
Intervention: Control (Fluoxetine)
Number of subjects: 45
Study 11167284 — intervention group
Group type: EXPERIMENTAL
Intervention: SF6 20%
Number of subjects: 33
Study 11167284 — intervention group
Group type: COMPARATOR
Intervention: BSS
Number of subjects: 33
Study 9808215 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based aerobic exercise program (15-min walk and 20-min aerobic dance, 3 times a week for 29.6 weeks)
Number of subjects: 292
Study 9808215 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 292
Study 9808215 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based aerobic exercise program
Number of subjects: 292
Study 7697842 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful balloon dilatation of coronary occlusions
Number of subjects: 2950
Study 7697842 — intervention group
Group type: COMPARATOR
Intervention: Successful balloon dilatation of total occlusions
Number of subjects: 2950
Study 2515306 — intervention group
Group type: EXPERIMENTAL
Intervention: IVN for 3 days (0.18 gN/kg/day as amino acid; 30 kcal/kg/day as glucose)
Number of subjects: 30
Study 2515306 — intervention group
Group type: EXPERIMENTAL
Intervention: IVN for 7 days
Number of subjects: 30
Study 2515306 — intervention group
Group type: COMPARATOR
Intervention: No IVN
Number of subjects: 30
Study 321704 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B immune globulin
Number of subjects: 235
Study 321704 — intervention group
Group type: COMPARATOR
Intervention: Immune serum globulin (control)
Number of subjects: 235
Study 30341143 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined steroid and mycophenolate mofetil (MMF)
Number of subjects: 120
Study 30341143 — intervention group
Group type: COMPARATOR
Intervention: Standard steroid treatment
Number of subjects: 120
Study 27741200 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy with somatosensory stimulation
Number of subjects: 67
Study 27741200 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 67
Study 24401240 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium soup containing 65 mmol Na
Number of subjects: 16
Study 24401240 — intervention group
Group type: COMPARATOR
Intervention: Low sodium soup containing 5 mmol Na
Number of subjects: 16
Study 23348639 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO group (12.5% dextrinomaltose)
Number of subjects: 36
Study 23348639 — intervention group
Group type: EXPERIMENTAL
Intervention: GLN group (12.5% dextrinomaltose and 40 and 10g of glutamine)
Number of subjects: 36
Study 23348639 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + GLN (shortened fasting period)
Number of subjects: 36
Study 23348639 — intervention group
Group type: COMPARATOR
Intervention: Fasting group
Number of subjects: 36
Study 19896353 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation training protocol, n=10, stimulated for 15min on each quadriceps femoris, three times per week for eight weeks
Number of subjects: 18
Study 19896353 — intervention group
Group type: COMPARATOR
Intervention: Control group, n=8, parallel clinical monitoring
Number of subjects: 18
Study 18797832 — intervention group
Group type: EXPERIMENTAL
Intervention: Early orthodontic treatment (bonded palatal expansion appliance and U-bow activator)
Number of subjects: 65
Study 18797832 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 65
Study 16213269 — intervention group
Group type: EXPERIMENTAL
Intervention: Open donor nephrectomy (n = 30)
Number of subjects: 100
Study 16213269 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic donor nephrectomy (n = 28)
Number of subjects: 100
Study 16213269 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified laparoscopic donor nephrectomy (n = 42)
Number of subjects: 100
Study 16213269 — intervention group
Group type: COMPARATOR
Intervention: All groups (open, laparoscopic, modified laparoscopic)
Number of subjects: 100
Study 12812627 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Renal Replacement Therapy (CRRT)
Number of subjects: 20
Study 12812627 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (without CRRT)
Number of subjects: 20
Study 10450833 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ENA), 10 mg o.d.
Number of subjects: 20
Study 10450833 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (NIT), 20 mg o.d.
Number of subjects: 20
Study 8931972 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 427
Study 8931972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study 1869063 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% carteolol
Number of subjects: 105
Study 1869063 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% carteolol
Number of subjects: 105
Study 1869063 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol
Number of subjects: 105
Study 6121605 — intervention group
Group type: EXPERIMENTAL
Intervention: lormetazepam 2 mg
Number of subjects: 97
Study 6121605 — intervention group
Group type: EXPERIMENTAL
Intervention: nitrazepam 5 mg
Number of subjects: 97
Study 6121605 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 97
Study 6361561 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole plus aspirin
Number of subjects: 407
Study 6361561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 407
Study 31577923 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 1000
Study 31577923 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement
Number of subjects: 1000
Study 29956318 — intervention group
Group type: EXPERIMENTAL
Intervention: Titration method
Number of subjects: 67
Study 29956318 — intervention group
Group type: COMPARATOR
Intervention: Standard method
Number of subjects: 67
Study 27114426 — intervention group
Group type: EXPERIMENTAL
Intervention: Inherited susceptibility educational module delivered by lay health educators in participants' homes
Number of subjects: 65
Study 27114426 — intervention group
Group type: EXPERIMENTAL
Intervention: Inherited susceptibility educational module
Number of subjects: 65
Study 25088637 — intervention group
Group type: EXPERIMENTAL
Intervention: HSM IOL (heparin-surface-modified hydrophobic acrylic intraocular lens)
Number of subjects: 50
Study 25088637 — intervention group
Group type: COMPARATOR
Intervention: Uncoated IOL
Number of subjects: 50
Study 25088637 — intervention group
Group type: EXPERIMENTAL
Intervention: HSM IOL
Number of subjects: 50
Study 22854110 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar electrocautery
Number of subjects: 60